Repligen (RGEN) Reports In-Line Q3 EPS

November 3, 2016 8:53 AM EDT
Get Alerts RGEN Hot Sheet
Trade RGEN Now!
Join SI Premium – FREE

Get the Pulse of the Market with's Pulse Picks. Get your Free Trial here.

Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.08, in-line with the analyst estimate of $0.08. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $24.39 million.


Repligen sees FY2016 EPS of $0.42-$0.48, versus the consensus of $0.44. Repligen sees FY2016 revenue of $102-105 million, versus the consensus of $104.0 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment